EDITORIAL
.
updated 
 
DISCLAIMER
.
I take no responsibility for the timeliness or accuracy of the contents of this page. However, I have verified the information to the best of my ability. The source of the information is noted wherever possible. Please inform me of any errors or omissions you may find.
.
Should you find yourself inclined to invest in this company, do your own homework
 
A few words on the infamous '50 million'.
January 24, 1998
There has been more than enough speculation on this issue. What we actually 'know' is that fifty million shares used as collateral for a loan given by 'four entities' during the 'dark ages' of Eutro has in part or in full been traded into the float. This fact has not been officially verified by the company since it was first reported by a user on Silicon Investor. The user (whose name eludes me) said that he had been told this by Brad Wilkenson of Eutro IR fame. 

A statement in the Eutro newsletter #3 talks about money owed on stock sold during the same 'dark ages' as above. This has caused some confusion. Let's take a look at the actual statement (the 'first topic' is over on the history page): 

    The second topic concerns obligations to Eutro in both stock and cash by certain parties. As you already know, during the recent lean times we had to obtain funds with which to pay expenses by effecting private placements of Eutro common stock. Some of the persons who bought the stock have not paid the total amount owing on it. We have been trying for some time to get these persons to pay the amount owing or return the stock. We have met with very limited success and we hereby inform you that we have resorted to legal means to obtain satisfaction. As with the first topic, you will be kept informed on this as you have on all matters affecting your company. 

    Eutro wants to take this opportunity to wish you all a happy holiday season as well as a healthy, happy and prosperous New Year.

The text speaks about stock sold not used as collateral. This leads to the conclusion that Eutro is making an official statement in an other issue here. Subsequent reports by shareholders that have talked to Brad has corroborated the hunch that Eutro has a problem with the '50 million' and the money owed as reported above. Brad has also, each time he has made comment about both issues, stated that Eutro is confident that they will be resolved to the benefit of Eutro. I am fairly sure that is the honest truth as seen from within Eutro. Let's hope the reality plays out along those lines as well. Also, the 'four entities' has been given a 30 day grace period in which to honor Eutro by buying back any sold stock and returning it to Eutro. This grace period ends about right now. 

Fact: there are no official public statements on the '50 million' from Eutro. Legal council has since put a zip lock on Eutro IR regarding this issue. 

This is my account of the situation. Since much information is based on hearsay and conclusion drawn from second hand information and, I am sure, opinion, I welcome any information that brings this editorial closer to real life.

 
Update on Freedom & Santiago
January 24, 1998
I swiped a piece of info from SI, thanx to E Richter for this tidbit: 
 
    To: +MrBuzz (1185 )  
    From: +E Richter  
    Sunday, Jan 25 1998 2:18AM EST 
    Reply #  of 1187  

    I spoke with Brad on Thursday. Freedom Medical should start trading in about 2 months. There are some problems with Santiago Cigar, partly because SEC prefers established companies to startups. He could not give me a trading date for them. (no more dividends for a while) As far as the third company that was mentioned in the Santiago news release, and others that they are talking with, EUTO are doing more research on companies before they sign a contract with them to avoid possible problems in the future. 
     

That would put the Freedom Medical launch at the end of March / beginning of April. The rate of customer launches is supposed to about six per year. That gives Eutro two months per company on average. Eutro has been close to Freedom Medical a long time so they should be the 'easiest' to bring public. The real test of Eutros character will be the subsequent deals. 

I have had a feeling that the SEC debacle a while back with new requirements for OTCBB's and all has created some additional hurdles for Eutro to lug their customers (Freedom Medical et al.) over. Ironical if so, first they come back from never never land and then the rules change. I have a feeling we're in a period with above average friction for Eutro. Being humans, they are doing an excellent job so far. I guess this year will be mostly spent resolving old problems and adjusting to the new quirks of the trade. Should the guys at Eutro proceed through '98 with the same zeal as in '97 I think we will more than ok.

 
Eutros 'first' year
January 23, 1998
The reformed Eutro just recently celebrated their first anniversary the fifteenth of January. The past year has been, shall we say, 'volatile' in the least. The miraculous recovery from the incredible lows during the late summer brought equally incredible spikes when rumors of a short squeeze developed. The spikes reached above fifty cents for a short while probably due to massive momentum trading and subsequent profit taking. 

The short squeeze campaign held the stock at a dime for months until information leaked out that 50 million shares that was supposed to be held as collateral for a loan actually had been traded and was in part or fully in the float. This caused a massive selloff eventually bringing the stock to the three cent range. The selloff was most certainly taken advantage off by short sellers helping to drive the price further down. A statement by the company that the 50 million 'loose' shares would be taken care of and be returned to the company initiated a mild recovery. The deadline for the return has been a matter of debate but January 23-ish has been the consensus among many. No official statement has yet been issued in the matter. 

In a clever move by Eutro to bring the stock closer to its true value a dividend of sorts was publicly announced. All shareholders are to receive a portion of the stock Eutro was paid when bringing Freedom Medical public. The statement brought a momentum based spike and left the stock building base at a higher level of about six cents. The irony is that Eutro had announced that they would use this tactic much earlier. I cannot readily find that statement now but I think it is somewhere in the investors packet. Pointers anyone? [Edited: I have been advised that 'dividends' of this sort was discussed in latest Eutro newsletter (#3), my copy is post marked December 16, 1997. It states that Eutro will do this with all applicable companies they bring public. It also talks about the six month delay SEC imposes. Thanx to John Algermissen for that.] However, this move has shaken out any weak shorters. To be recorded for the dividend your holdings at the last of January is used. 

Currently I think we are 'enjoying' an interesting equilibrium with money chasing the dividend going into the stock and restless money leaving that came in in December 97 hoping for a quick solution to the 50 million shares. Due to the late date most have made their move, the volume is down and the tension is up. If my reasoning holds we will see some volatility up ahead.

 
Important
January 23, 1998
This is the first editorial on Eutro Group Holding, Inc. Being an editorial I will from time to time make guesses and draw far fetched conclusions on little if any data. I am not paid by or affiliated to anyone. These are my own thoughts and conclusions. I do this for fun and education and I am hoping that these pages will be driven to some extent by feedback. The disclaimer goes double for this page! I will present my guesses but you are the only one responsible for acting on it.